drugset
drugset / Trial / NCT04865835

A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

NCT04865835 ↗

Phase 1 Completed 21 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
RandomizedCrossoverSingle-blindTreatment

Summary

A clinical trial study to determine the effect of an investigational drug (SEP-363856) has on the way that the drug Metformin travels through the body in people with schizophrenia. This clinical trial will have approximately 24 subjects both male and female 18 year of age and older. This study will be conducted in approximately 2 study sites in the United States.

Timeline

Start
2021-05-12
Primary completion
2022-05-03
Completion
2022-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg —
Subject Ulotaront Small molecule 100 mg —

Indications

schizophrenia